Inventor · disambiguated record
Oskar Kalb
Also filed as: KALB OSKAR · KALB OSKAR MICHAEL
7 granted patents·25 pending applications·126 citations·filing 2000–2015
86Inventor score
Top patents by PatentIndex Score
32 records- 0187US6565883B2Controlled release oral compositions comprising rivastigmineNOVARTIS AG·Filed 2002·Granted May 20, 2003·39 cites·6 claims
- 0287US6242003B1Organic compoundsNOVARTIS AG·Filed 2000·Granted Jun 5, 2001·37 cites·30 claims
- 0376US6432447B2Organic compoundsNOVARTIS AG·Filed 2001·Granted Aug 13, 2002·10 cites·6 claims
- 0473USD520635SCombine capsule and tabletsNOVARTIS AG·Filed 2004·Granted May 9, 2006·22 cites·1 claims
- 0566US9011911B2High drug load tabletLUFTENSTEINER CHRISTIAN-PETER·Filed 2014·Granted Apr 21, 2015·2 cites·11 claims
- 0664USD530814SCombined capsule and tabletsNOVARTIS AG·Filed 2006·Granted Oct 24, 2006·16 cites·1 claims
- 0758US2010178336A1Stabilized amorphous forms of imatinib mesylateNOVARTIS AG·Filed 2008·Application pending·0 cites
- 0855US2007053982A1Sustained release oral formulationsOGORKA JORG·Filed 2006·Application pending·0 cites
- 0952US2013022672A1Stabilized Amorphous Forms of Imatinib MesylateNOVARTIS AG·Filed 2012·Application pending·0 cites
- 1051US2005175706A1Sustained release oral formulationsFiled 2005·Application pending·0 cites
- 1151US2006127474A1Pharmaceutical compositions comprising fluvastatinKALB OSKAR·Filed 2006·Application pending·0 cites
- 1249US8303987B2Pharmaceutical compositions comprising fluvastatinKALB OSKAR·Filed 2010·Granted Nov 6, 2012·0 cites·14 claims
- 1349US2014323495A1Stabilized Amorphous Forms of Imatinib MesylateGONCALVES ELISABETE·Filed 2014·Application pending·0 cites
- 1449US2008286356A1Pharmaceutical compositions containing terbinafin and use thereofALLES RAINER·Filed 2008·Application pending·0 cites
- 1549US2003203025A1Sustained release oral formulationsFiled 2003·Application pending·0 cites
- 1647US2012177737A1High drug load tabletLUFTENSTEINER CHRISTIAN-PETER·Filed 2012·Application pending·0 cites
- 1747US2006246101A1Oral controlled release formulationsSHAH RAJEN·Filed 2006·Application pending·0 cites
- 1847US2010203133A1High drug load tabletNOVARTIS AG·Filed 2010·Application pending·0 cites
- 1946US2013225598A1Stabilized Amorphous Forms of Imatinib MesylateGONCALVES ELISABETE·Filed 2013·Application pending·0 cites
- 2045US2001033866A1Sustained release oral formulationsFiled 2001·Application pending·0 cites
- 2145US2016101105A1High drug load tabletLUFTENSTEINER CHRISTIAN-PETER·Filed 2015·Application pending·0 cites
- 2244US2010022565A1Pharmaceutical compositionsBUHL THOMAS·Filed 2008·Application pending·0 cites
- 2344US2004198838A1Pharmaceutical compositions containig terbinafin and use thereofFiled 2002·Application pending·0 cites
- 2444US2005267125A1High drug load tabletLUFTENSTEINER CHRISTIAN-PETER·Filed 2003·Application pending·0 cites
- 2543US2015209291A1High drug load tabletLUFTENSTEINER CHRISTIAN-PETER·Filed 2015·Application pending·0 cites
- 2643US2003171419A1Pharmaceutical compositions comprising fluvastatinFiled 2001·Application pending·0 cites
- 2738US2011038897A1Oral controlled release formulationsSHAH RAJEN·Filed 2010·Application pending·0 cites
- 2837US2008050443A1Fast Release Composition Including Melt Granules of a Moisture Sensitive Drug and Process for Manufacturing ThereofKOWALSKI JAMES·Filed 2005·Application pending·0 cites
- 2933US2007196488A1Oral matrix formulations comprising licarbazepineKALB OSKAR·Filed 2005·Application pending·0 cites
- 3033US2010015225A1Solid dispersion of a neurokinin antagonistDIEDERICH ANKE·Filed 2007·Application pending·0 cites
- 3133US2007190143A1Disintegrating tablets comprising licarb azepineKALB OSKAR·Filed 2005·Application pending·0 cites
- 3232US2008213385A1Formulations for 7- (T-Butoxy) Iminomethyl CamptothecinKALB OSKAR·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Oskar Kalb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →